<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[NOVO — Juni 2025]]></title><description><![CDATA[<p dir="auto">Lukke kursen i us fredag indikerede en pæn stigning til Novo mandag. Det ville være godt at få kursen i plus 500 i juni.</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400322/novo-juni-2025</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 04:40:56 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400322.rss" rel="self" type="application/rss+xml"/><pubDate>Sun, 01 Jun 2025 16:37:11 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to NOVO — Juni 2025 on Mon, 30 Jun 2025 09:12:21 GMT]]></title><description><![CDATA[<p dir="auto">I aften på tv3 - the Ozempic revolution <a href="https://www.tvguide.dk/programmer/tv3/2025-06-30/21:30/big-shot-the-ozempic-revolution" rel="nofollow ugc">https://www.tvguide.dk/programmer/tv3/2025-06-30/21:30/big-shot-the-ozempic-revolution</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985787</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985787</guid><dc:creator><![CDATA[Svingtraderen]]></dc:creator><pubDate>Mon, 30 Jun 2025 09:12:21 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Mon, 30 Jun 2025 07:40:35 GMT]]></title><description><![CDATA[<p dir="auto">Novo får ny konkurrent på fedmemarkedet i Kina <a href="https://proinvestor.com/investornyt/1334510/novo-far-ny-konkurrent-pa-fedmemarkedet-i-kina" rel="nofollow ugc">https://proinvestor.com/investornyt/1334510/novo-far-ny-konkurrent-pa-fedmemarkedet-i-kina</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985785</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985785</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 30 Jun 2025 07:40:35 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Mon, 30 Jun 2025 06:37:12 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk: Fra darling til investorskepsis på 12 måneder <a href="https://proinvestor.com/boards/127061" rel="nofollow ugc">https://proinvestor.com/boards/127061</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985786</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985786</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 30 Jun 2025 06:37:12 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Mon, 30 Jun 2025 06:13:20 GMT]]></title><description><![CDATA[<p dir="auto">Ja, Kina. Er der nogen af jer der kan overskue den konkurrence fra Kina - læser meget gerne om det. Tak</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985781</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985781</guid><dc:creator><![CDATA[ungeee]]></dc:creator><pubDate>Mon, 30 Jun 2025 06:13:20 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Mon, 30 Jun 2025 03:24:29 GMT]]></title><description><![CDATA[<p dir="auto">Innovent's Lilly-partnered obesity asset wins approval in China <a href="https://firstwordpharma.com/story/5976911" rel="nofollow ugc">https://firstwordpharma.com/story/5976911</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985784</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985784</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 30 Jun 2025 03:24:29 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Sat, 28 Jun 2025 10:02:50 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk, Eli Lilly: "Skildpadden og Haren" <a href="https://proinvestor.com/boards/127050" rel="nofollow ugc">https://proinvestor.com/boards/127050</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985780</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985780</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 28 Jun 2025 10:02:50 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Fri, 27 Jun 2025 18:32:44 GMT]]></title><description><![CDATA[<p dir="auto">..Eli lily er måske ved at møde lidt modstand fra FDA..</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985783</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985783</guid><dc:creator><![CDATA[vestasfan]]></dc:creator><pubDate>Fri, 27 Jun 2025 18:32:44 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Fri, 27 Jun 2025 18:26:33 GMT]]></title><description><![CDATA[<p dir="auto">Prøv at google Eli Lily problems</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985777</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985777</guid><dc:creator><![CDATA[vestasfan]]></dc:creator><pubDate>Fri, 27 Jun 2025 18:26:33 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Fri, 27 Jun 2025 13:49:29 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk har i den forgangne uge igen været et af de helt store samtaleemner på <a href="http://ProInvestor.com" rel="nofollow ugc">ProInvestor.com</a>. Denne gang er det en droppet aftale med Hims &amp; Hers, der fik aktiekursen til atter at droppe. Efterfulgt af en nyhed, der fik kursen lidt tilbage på sporet, nemlig et samarbejde med Weight Watchers. Så handler denne ugekommentar også om Gubra og udbytte, og om hvorvidt Zealand Pharma burde gøre det samme. Kort video: <a href="https://proinvestor.com/boards/127044" rel="nofollow ugc">https://proinvestor.com/boards/127044</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985776</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985776</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 27 Jun 2025 13:49:29 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Fri, 27 Jun 2025 02:46:05 GMT]]></title><description><![CDATA[<p dir="auto">Altimmune's incretin can't make good on fibrosis improvement promises <a href="https://firstwordpharma.com/story/5976630" rel="nofollow ugc">https://firstwordpharma.com/story/5976630</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985782</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985782</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 27 Jun 2025 02:46:05 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Thu, 26 Jun 2025 17:21:55 GMT]]></title><description><![CDATA[<p dir="auto">Altimmune falder mere end 50% på børsen i dag.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985774</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985774</guid><dc:creator><![CDATA[YPE]]></dc:creator><pubDate>Thu, 26 Jun 2025 17:21:55 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Thu, 26 Jun 2025 14:09:00 GMT]]></title><description><![CDATA[<p dir="auto">Novo indgår nyt samarbejde for Wegovy med Weightwatchers i USA <a href="https://proinvestor.com/investornyt/1333627/novo-indgar-nyt-samarbejde-for-wegovy-med-weightwatchers-i-usa" rel="nofollow ugc">https://proinvestor.com/investornyt/1333627/novo-indgar-nyt-samarbejde-for-wegovy-med-weightwatchers-i-usa</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985773</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985773</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 26 Jun 2025 14:09:00 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Thu, 26 Jun 2025 09:31:51 GMT]]></title><description><![CDATA[<p dir="auto">Novo-rival har lovende resultater med blødermedicin <a href="https://proinvestor.com/investornyt/1333420/novo-rival-har-lovende-resultater-med-blodermedicin" rel="nofollow ugc">https://proinvestor.com/investornyt/1333420/novo-rival-har-lovende-resultater-med-blodermedicin</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985771</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985771</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 26 Jun 2025 09:31:51 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Thu, 26 Jun 2025 09:26:20 GMT]]></title><description><![CDATA[<p dir="auto">Novo-rival gearer op i Indien <a href="https://proinvestor.com/investornyt/1333361/novo-rival-gearer-op-i-indien" rel="nofollow ugc">https://proinvestor.com/investornyt/1333361/novo-rival-gearer-op-i-indien</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985778</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985778</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 26 Jun 2025 09:26:20 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Wed, 25 Jun 2025 14:20:27 GMT]]></title><description><![CDATA[<p dir="auto">Health Rounds: Inhaled insulin as good as injection for children at mealtime - <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/health-rounds-inhaled-insulin-good-injection-children-mealtime-2025-06-25/" rel="nofollow ugc">https://www.reuters.com/business/healthcare-pharmaceuticals/health-rounds-inhaled-insulin-good-injection-children-mealtime-2025-06-25/</a> Reuters</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985772</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985772</guid><dc:creator><![CDATA[bb8]]></dc:creator><pubDate>Wed, 25 Jun 2025 14:20:27 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Wed, 25 Jun 2025 13:10:19 GMT]]></title><description><![CDATA[<p dir="auto">Hvordan påvirker den geopolitiske uro i Mellemøsten de globale aktiemarkeder? Ugens afsnit af Investeringspodcasten dykker ned i investorernes reaktioner og markedets udvikling.</p>
<p dir="auto">I dette afsnit får du også:</p>
<p dir="auto">Seneste nyt om Novo Nordisk: Ny data og afbrudt samarbejde<br />
Indblik i Teslas robottaxi og hvad det kan betyde for aktien <a href="https://proinvestor.com/boards/127002" rel="nofollow ugc">https://proinvestor.com/boards/127002</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985779</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985779</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 25 Jun 2025 13:10:19 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Wed, 25 Jun 2025 12:18:43 GMT]]></title><description><![CDATA[<p dir="auto">Håber alt muligt hed og lykke fremover for mine medinvestorer i Novo. Det kan næsten kun blive bedre.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985769</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985769</guid><dc:creator><![CDATA[NickKH]]></dc:creator><pubDate>Wed, 25 Jun 2025 12:18:43 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Wed, 25 Jun 2025 12:18:20 GMT]]></title><description><![CDATA[<p dir="auto">Ja Novo Nordisk = Mavepine, det er stensikkert.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985767</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985767</guid><dc:creator><![CDATA[NickKH]]></dc:creator><pubDate>Wed, 25 Jun 2025 12:18:20 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Wed, 25 Jun 2025 04:01:46 GMT]]></title><description><![CDATA[<p dir="auto"><a href="https://medwatch.dk/resultater/article18302669.ece?utm_campaign=MedWatch%20Morgen&amp;utm_content=2025-06-25&amp;utm_medium=email&amp;utm_source=medwatch" rel="nofollow ugc">https://medwatch.dk/resultater/article18302669.ece?utm_campaign=MedWatch Morgen&amp;utm_content=2025-06-25&amp;utm_medium=email&amp;utm_source=medwatch</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985768</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985768</guid><dc:creator><![CDATA[Sukkeralf]]></dc:creator><pubDate>Wed, 25 Jun 2025 04:01:46 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Wed, 25 Jun 2025 03:51:02 GMT]]></title><description><![CDATA[<p dir="auto">Novo-rival har store forventninger til ny vægttabspille <a href="https://proinvestor.com/investornyt/1332887/novo-rival-har-store-forventninger-til-ny-vaegttabspille" rel="nofollow ugc">https://proinvestor.com/investornyt/1332887/novo-rival-har-store-forventninger-til-ny-vaegttabspille</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985764</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985764</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 25 Jun 2025 03:51:02 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Wed, 25 Jun 2025 02:28:07 GMT]]></title><description><![CDATA[<p dir="auto">BrightGene Pharmaceutical reported upbeat mid-stage results for its investigational dual GLP-1/GIP agonist BGM0504, demonstrating superior glycaemic control over Novo Nordisk’s GLP-1 agonist Wegovy/Ozempic (semaglutide) in patients with type 2 diabetes, along with significant weight reduction in obese individuals. The data were presented at the American Diabetes Association (ADA) annual meeting. <a href="https://firstwordpharma.com/story/5975593" rel="nofollow ugc">https://firstwordpharma.com/story/5975593</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985770</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985770</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 25 Jun 2025 02:28:07 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Tue, 24 Jun 2025 12:01:30 GMT]]></title><description><![CDATA[<p dir="auto">Novos opsagte partner trues af søgsmål fra investorer <a href="https://proinvestor.com/investornyt/1332545/novos-opsagte-partner-trues-af-sogsmal-fra-investorer" rel="nofollow ugc">https://proinvestor.com/investornyt/1332545/novos-opsagte-partner-trues-af-sogsmal-fra-investorer</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985766</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985766</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 24 Jun 2025 12:01:30 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Tue, 24 Jun 2025 08:20:39 GMT]]></title><description><![CDATA[<p dir="auto">Novo genvinder en smule terræn efter afbrudt Hims &amp; Hers-partnerskab <a href="https://proinvestor.com/investornyt/1332448/novo-genvinder-en-smule-terraen-efter-afbrudt-hims-hers-partnerskab" rel="nofollow ugc">https://proinvestor.com/investornyt/1332448/novo-genvinder-en-smule-terraen-efter-afbrudt-hims-hers-partnerskab</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985775</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985775</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 24 Jun 2025 08:20:39 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Juni 2025 on Tue, 24 Jun 2025 07:51:14 GMT]]></title><description><![CDATA[<p dir="auto">Ja det er super fint, men ingen nævner noget om, at patentet på Wegovy udløber 1. kvartal 2026. Om otte mdr.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7985761</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7985761</guid><dc:creator><![CDATA[vestasfan]]></dc:creator><pubDate>Tue, 24 Jun 2025 07:51:14 GMT</pubDate></item></channel></rss>